Luye Pharma Group Ltd. (FRA:LUP)

Luye Pharma Group Statistics

Total Valuation

FRA:LUP has a market cap or net worth of EUR 1.35 billion. The enterprise value is 1.95 billion.

Market Cap	1.35B
Enterprise Value	1.95B

Important Dates

The last earnings date was Monday, November 17, 2025.

Earnings Date	Nov 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	3.99B
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	26.62%
Float	2.20B

Valuation Ratios

The trailing PE ratio is 28.71.

PE Ratio	28.71
Forward PE	n/a
PS Ratio	1.85
PB Ratio	0.69
P/TBV Ratio	1.65
P/FCF Ratio	6.50
P/OCF Ratio	4.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.15, with an EV/FCF ratio of 9.34.

EV / Earnings	41.25
EV / Sales	2.61
EV / EBITDA	8.15
EV / EBIT	14.24
EV / FCF	9.34

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.72.

Current Ratio	1.31
Quick Ratio	1.04
Debt / Equity	0.72
Debt / EBITDA	5.98
Debt / FCF	6.77
Interest Coverage	1.84

Financial Efficiency

Return on equity (ROE) is 3.68% and return on invested capital (ROIC) is 2.75%.

Return on Equity (ROE)	3.68%
Return on Assets (ROA)	2.41%
Return on Invested Capital (ROIC)	2.75%
Return on Capital Employed (ROCE)	5.69%
Revenue Per Employee	143,330
Profits Per Employee	9,224
Employee Count	5,150
Asset Turnover	0.21
Inventory Turnover	2.42

Taxes

In the past 12 months, FRA:LUP has paid 24.09 million in taxes.

Income Tax	24.09M
Effective Tax Rate	26.43%

Stock Price Statistics

The stock price has increased by +10.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+10.53%
50-Day Moving Average	0.35
200-Day Moving Average	0.33
Relative Strength Index (RSI)	44.85
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:LUP had revenue of EUR 733.13 million and earned 47.18 million in profits. Earnings per share was 0.01.

Revenue	733.13M
Gross Profit	490.10M
Operating Income	135.78M
Pretax Income	91.15M
Net Income	47.18M
EBITDA	232.45M
EBIT	135.78M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 1.05 billion in cash and 1.41 billion in debt, giving a net cash position of -361.05 million.

Cash & Cash Equivalents	1.05B
Total Debt	1.41B
Net Cash	-361.05M
Net Cash Per Share	n/a
Equity (Book Value)	1.97B
Book Value Per Share	0.46
Working Capital	445.51M

Cash Flow

In the last 12 months, operating cash flow was 278.91 million and capital expenditures -70.61 million, giving a free cash flow of 208.30 million.

Operating Cash Flow	278.91M
Capital Expenditures	-70.61M
Free Cash Flow	208.30M
FCF Per Share	n/a

Margins

Gross margin is 66.85%, with operating and profit margins of 18.52% and 6.44%.

Gross Margin	66.85%
Operating Margin	18.52%
Pretax Margin	12.43%
Profit Margin	6.44%
EBITDA Margin	31.71%
EBIT Margin	18.52%
FCF Margin	28.41%

Dividends & Yields

FRA:LUP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	3.48%
FCF Yield	15.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:LUP has an Altman Z-Score of 1.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.16
Piotroski F-Score	6